Abcam Share Price (ABC)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Abcam Plc	LSE:ABC	London	Ordinary Share	GB00B6774699	ORD 0.2P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-6.00	-0.52%	1,150.00	168,170	16:29:48

Bid Price		Offer Price	High Price	Low Price	Open Price
1,150.00		1,151.00	1,157.00	1,148.00	1,151.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	259.90	56.40	22.00	52.3	2,364

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
17:42:45	O	227	1,152.242	GBX

Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Agronomics (ANIC), Valirx (VAL)

Abcam (ABC) Latest News

Abcam News

Date	Time	Source	Headline
02/10/2019	16:28	UKREG	ABCAM PLC Holding(s) in Company
02/10/2019	13:49	UKREG	ABCAM PLC Director/PDMR Shareholding
01/10/2019	14:22	UKREG	ABCAM PLC Total Voting Rights
30/9/2019	13:35	UKREG	ABCAM PLC Annual Financial Report
30/9/2019	08:00	ALNCF	Alliance News Flash Headline
26/9/2019	14:30	UKREG	ABCAM PLC Director/PDMR Shareholding
25/9/2019	14:04	ALNC	Mercia's Investee Expands Engineered Cell Lines Contract With Abcam
16/9/2019	08:02	UKREG	ABCAM PLC Director/PDMR Shareholding
12/9/2019	07:00	UKREG	ABCAM PLC Notice of Capital Markets Event
11/9/2019	10:33	UKREG	ABCAM PLC Director/PDMR Shareholding

More Abcam News

Abcam Takeover Rumours

Abcam (ABC) Share Charts

1 Year Abcam Chart

1 Month Abcam Chart

Intraday Abcam Chart

Abcam (ABC) Discussions and Chat

Abcam Forums and Chat

Date	Time	Title	Posts
04/10/2019	20:46	ABCAM with Charts & News	141
19/11/2017	20:07	Investing ? Start with your ABC's	703
03/8/2017	11:31	Abcam	-
29/8/2013	23:08	ABCAM - another e-Commerce Retailer	120
07/2/2013	17:29	abc	1

Add a New Thread

Abcam (ABC) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:43:44	1,152.24	227	2,615.59	O
16:36:22	1,149.95	1,539	17,697.79	O
16:16:03	1,149.94	340	3,909.81	O
15:39:11	1,149.97	8,350	96,022.20	O
15:35:29	1,150.00	44,840	515,660.00	UT

View all Abcam trades in real-time

Abcam (ABC) Top Chat Posts

Date	Subject
18/10/2019 09:20	Abcam Daily Update: Abcam Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker ABC. The last closing price for Abcam was 1,156p. Abcam Plc has a 4 week average price of 1,082p and a 12 week average price of 1,082p. The 1 year high share price is 1,523p while the 1 year low share price is currently 1,006p. There are currently 205,597,614 shares in issue and the average daily traded volume is 374,077 shares. The market capitalisation of Abcam Plc is £2,364,372,561. Read Full Thread Reply
10/9/2019 11:23	mw8156: significant fall in the share price might result in it being taken over as the leading antibody company, their cash generative nature and their huge catalogue of 18000 validated antibodies and that would be Britain's only leading life sciences tools company disappearing which would be a shame after Illumina snapped up our sequencing technology. Read Full Thread Follow Reply
09/9/2019 08:37	erogenous jones: City did not like the figures. Sharp rises and sharp falls (in the share price) are normal for this company. Read Full Thread Follow Reply
05/3/2019 15:26	erogenous jones: Not in the least fussed about the drop yesterday, or the rise today, for that matter. Good, well managed and profitable company that has a track record of share price growth over many years. That was the case last week and remains the case this week. My average price is £6.50 and until the company ceases to be as profitable as in previous years I see no reason why I should not allow profits to run. Read Full Thread Follow Reply
12/12/2018 16:05	investorschampion: Milner's wife recently bought £2m worth of shares. It's a nice confidence booster following the recent share price weakness, but perhaps some executive directors should follow suit? hxxps://www.investorschampion.com/channel/blog/follow-the-directors-whos-buying Read Full Thread Follow Reply
07/12/2018 11:31	jurgenklopp: With regards to the large PDMR purchase yesterday it should be noted that Milner sold over 1 million shares at £14.41 as recently as late September. However re-investing 2 million quid back in company shares ought to provide some kind of support to the share price in these strange times !! Read Full Thread Follow Reply
03/11/2016 11:09	shawzie: I can only agree with Panmure that the current share price overvalues this Company. Earnings fairly static on increasing turnover. Intangibles increasing rapidly, but not reflected in increased earnings. Increase in Net Worth of Company due mainly to increase in Intangibles. Does anyone have a more optimistic view? Read Full Thread Follow Reply
25/1/2016 11:48	campbed: Very good trading update today outlining progress on all fronts. A great British success story . Share price at 640p almost back to the all time high of 660p reached at end of 2015 before the market-wide Jan sell off. Read Full Thread Follow Reply
31/1/2015 10:42	apad: Slater in the Telegraph today - with any luck that should drive the share price down for those who are looking for an entry point. apad . .R01;and some can be disastrous Other Aim shares that are favourites of veteran IHT investors are Young & Co’s Brewery, Advanced Medical Solutions and Abcam. All three are good sound companies but it seems to me that their share prices are living on the memory of their excellent past growth. Nowadays their p/e ratios are in or around the 20s with only single-digit earnings growth forecast. They are not for me because the slightest upset in their earnings growth could cause a major setback in their shares. Read Full Thread Follow Reply
20/5/2014 07:56	simon gordon: Unicorn AIM VCT - 20/5/14 Abcam (-23%) is a global leader in the supply of innovative protein research tools. In March 2014, Abcam released its financial results for the six month period ended 31 December 2013, which were in line with your Investment Manager's internal forecasts. Revenues of £61.9m (H2 2012: £57.3m) represented half-year on half-year growth of over 8%, while earnings per share were up 6.5% to 8.74p (H2 2012: 8.21p). Abcam remains a cash generative business with a robust balance sheet. Net cash balances at the period end amounted to £35.3m. Despite Abcam's many obvious qualities, market reaction to the release of Interim Results in early March was negative as investors worried about currency headwinds and the impact of possible cuts to health budgets in the key North American market, which accounts for 43% of total sales. As a result, Abcam's share price ended the period markedly lower. The holding has been retained in the portfolio in the expectation that the de-rating in the value of Abcam will prove to be temporary. Read Full Thread Follow Reply
06/3/2014 07:27	richscotsman: Buy into Abcam as share price drops, says Numis Antibody supplier Abcam (ABC.L) has been upgraded from 'hold' to 'buy' by Numis analyst Charles Weston. Weston placed a target price of 510p on the shares despite a sharp drop in the share price earlier in the week as it revealed sluggish Japanese growth despite the Japanese government investing in research. 'We are upgrading our recommendation to 'buy', from 'hold', following the sharp fall in the share price [on Wednesday morning],' he said. 'In our view little has changed in the fundamental investment thesis for Abcam and history has taught us that periods of weakness in its share price are the right time to buy into its highly defensive business model.' Weston said he 'expected margins and cash generation to remain high due to the characteristics of the product and Abcam's digital platform' and that management's investment in new growth initiatives has 'yet to translate to accelerating growth rates, which could start to be delivered over the next six-12 months'. Read Full Thread Follow Reply

Abcam share price data is direct from the London Stock Exchange

Your Recent History

LSE

ABC

Abcam

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20191018 17:03:57